TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 45 filers reported holding TERNS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,169,000 | -32.0% | 874,600 | -18.6% | 0.09% | -5.2% |
| Q1 2022 | $3,192,000 | -52.5% | 1,074,834 | +13.2% | 0.10% | -70.8% |
| Q4 2021 | $6,715,000 | -16.8% | 949,834 | +22.6% | 0.33% | -46.3% |
| Q3 2021 | $8,074,000 | -15.1% | 774,834 | -0.1% | 0.62% | +19.1% |
| Q2 2021 | $9,513,000 | -41.5% | 775,934 | +3.2% | 0.52% | -62.1% |
| Q1 2021 | $16,275,000 | – | 751,813 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,657,992 | $33,489,700 | 3.67% |
| ACUTA CAPITAL PARTNERS, LLC | 555,260 | $2,792,958 | 1.87% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,041,910 | $30,390,807 | 1.64% |
| VR Adviser, LLC | 3,092,273 | $15,554,133 | 1.64% |
| Fairmount Funds Management LLC | 2,040,000 | $10,261,200 | 1.24% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $3,592,854 | 1.20% |
| Deep Track Capital, LP | 6,000,000 | $30,180,000 | 1.16% |
| Orbimed Advisors | 7,619,135 | $38,324,249 | 0.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $2,515,000 | 0.76% |
| GREAT POINT PARTNERS LLC | 645,899 | $3,248,872 | 0.59% |